Researcher
Ying Zhang earned her bachelor’s degree from Zhejiang University, China, and pursued her PhD degree in cancer epigenetics at the National University of Singapore under a CSI scholarship. She subsequently completed a two-year postdoctoral fellowship at the Cancer Science Institute of Singapore under Melissa Jane Fullwood, where she became the first to define super-silencers and elucidate their roles in cancer. Zhang is currently a Scientist at the A*STAR Genome Institute of Singapore, where she works under Wai Leong Tam, focusing on cancer evolution, genomics and metabolism. As a cancer biologist and computational biologist, her research centers on 3D genome organisation, dysregulated metabolism and tumour evolution in cancer.
Zhang has authored several first and co-first author publications in high-impact journals including Nature Structural & Molecular Biology, Journal of Hepatology, Gastroenterology and Nature Communications.
Related Articles
Liver cancer’s ‘bad apple’ effect
19 Feb 2025A comprehensive study of liver tumours reveals that a small fraction of aggressive cells can



